Background: Atrial fibrillation (AF) is one of the known complications of cardiac surgery and represents a major cause of
morbidity. However, improvements in surgical and anaesthesia technique and controlling various predisposing factors have not
helped to curb the incidence. Therefore, search is going on for various modalities to decrease the incidence.
Aim: This retrospective study was conducted to evaluate the risk of AF with nebulised ß2 agonists in postoperative cardiac
bypass surgery patients.
Methods: In this observational study, data of 100 eligible patients operated for coronary artery bypass grafting (CABG) was collected.
Patients were divided in two groups:
Group A: Patients who had received postoperative nebulised salbutamol
Group B: Patients who had not received postoperative nebulised salbutamol
The data was analyzed for onset, duration, severity, treatment, outcome of post operative AF (POAF) and also regarding dose,
duration of salbutamol.
Results: POAF occurred frequently in patients who had received nebulised salbutamol (p
Atrial fibrillation, ß2 agonists, Post cardiac surgery patients, Salbutamol nebulisation